Assessing Precigen: Insights From 5 Financial Analysts
Portfolio Pulse from Benzinga Insights
Five financial analysts have recently provided ratings on Precigen (NASDAQ:PGEN), ranging from bullish to somewhat bullish. The average 12-month price target has decreased by 12.77% to $8.2. Analysts have adjusted their ratings and price targets in response to market conditions and company performance.
August 15, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Five analysts have provided mixed ratings on Precigen (NASDAQ:PGEN) with an average 12-month price target of $8.2, a 12.77% decrease from the previous target. Recent adjustments include both lowered and raised price targets.
The mixed ratings and adjustments in price targets indicate uncertainty among analysts about Precigen's short-term performance. The decrease in the average price target suggests a cautious outlook, but the presence of both raised and lowered targets reflects differing opinions on the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100